Testing how well imiquimod works for abnormal cervix cell changes
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cervical biopsy shows CIN2 or CIN3 (high-grade precancer), either as a new primary finding or as persistent/recurrent after LLETZ.
- Your case is NOT also a vaginal precancer (VAIN).
- You have not already taken imiquimod for this cervical condition before.
- You are not currently pregnant.
- You can communicate in Dutch well enough to understand study information and instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This study tests whether honey applied directly to the cervix can help reverse moderate cervical cell changes (CIN II). It may offer a natural alternative to more invasive procedures.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This trial tests if imiquimod cream can help clear high-grade cervical lesions caused by high-risk HPV. It may be an option for people who want to avoid surgery.
This study tests a topical gel made from curcumin (a compound in turmeric) to see if it can help clear abnormal cervical cells caused by HPV. It may be an option for women with low-grade changes or who have recently had high-grade changes treated.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
Hear when a new Cervical Intraepithelial Neoplasia Grade 2/3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.